Dextech Medical AB (XSAT:DEX)
10.90
-0.05 (-0.46%)
At close: Jun 12, 2026
Dextech Medical AB Revenue
Dextech Medical AB had revenue of 1.60M SEK in the quarter ending March 31, 2026, with 211.07% growth. This brings the company's revenue in the last twelve months to 4.15M, down -2.06% year-over-year. In the fiscal year ending June 30, 2025, Dextech Medical AB had annual revenue of 3.22M, down -40.15%.
Revenue (ttm)
4.15M
Revenue Growth
-2.06%
P/S Ratio
48.53
Revenue / Employee
4.15M
Employees
1
Market Cap
201.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.22M | -2.16M | -40.15% |
| Jun 30, 2024 | 5.39M | -3.33M | -38.18% |
| Jun 30, 2023 | 8.71M | 5.60M | 179.60% |
| Jun 30, 2022 | 3.12M | 2.48M | 390.65% |
| Jun 30, 2021 | 634.98K | 38.64K | 6.48% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sustainion Group AB | 579.82M |
| Angler Gaming | 336.78M |
| Gullberg & Jansson AB | 261.44M |
| SolidX AB | 137.67M |
| Krona Public Real Estate AB | 84.21M |
| BPC Instruments AB | 65.77M |
| Redsense Medical AB | 28.70M |
| PEPTONIC medical AB | 14.42M |
Dextech Medical AB News
- 5 weeks ago - Dextech Medical AB Quarterly report: Q3 2026 - Filings
- 3 months ago - Dextech Medical AB Quarterly report: Q2 2026 - Filings
- 7 months ago - Dextech Medical AB Quarterly report: Q1 2026 - Filings
- 10 months ago - Dextech Medical AB Annual report: Q4 2025 - Filings
- 10 months ago - Dextech Medical AB Quarterly report: Q4 2025 - Filings